Day: April 23, 2020

LEESBURG, Va., April 23, 2020 (GLOBE NEWSWIRE) — Quantum Computing Inc. (OTC:QUBT) (“QCI”), an advanced technology company developing quantum-ready applications and tools, announced today the release of version 1.1 of its Mukai middleware with new capabilities delivering higher performance and greater ease of use for subject-matter experts developing quantum-ready applications needing superior performance today.  The Mukai software stack (released in January 2020) can be used to solve extremely complex optimization problems.  Mukai enables developers to create and execute quantum-ready applications on classical computers, while being ready to run on quantum computers when those systems can achieve performance advantages. QCI has already demonstrated superior performance today for some applications built on Mukai and running on classical...

LAS VEGAS, April 23, 2020 (GLOBE NEWSWIRE) — Asia Broadband Inc. (AABB), through its wholly owned subsidiary Asia Metals Inc., announced today that the recent Bank of America gold forecast upgrade to $3,000 an ounce affirms the Company’s focus on mining production and facilities expansion in 2020. The recent economic conditions have created strong and unprecedented fundamentals for gold producer equities. The economic volatility and inflationary effects of the Coronavirus pandemic have launched gold and gold producers into a significant growth phase, which is expected to be heightened by the contraction of the general markets. Additionally, the recent collapse of the oil market has elevated the gold-to-oil ratio to all time highs indicating lower production costs and increased profit margins for gold producers. AABB is anticipating...

VANCOUVER and MINNEAPOLIS, MN, April 23, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and minimally invasive devices for the treatment of refractory angina, today announced that it will report financial results for the quarter ended March 31, 2020 after the market close on May 7, 2020.  Neovasc Chief Executive Officer Fred Colen and Chief Financial Officer Chris Clark will host a conference call to review the company’s results at 4:30 PM Eastern Time. Interested parties may access the conference call by dialing (888) 204-4368 or (856) 344-9299 (International).  Participants wishing to join the call via webcast should use the link posted on the investor relations section of the Neovasc website...

NEW YORK, April 23, 2020 (GLOBE NEWSWIRE) — via NetworkNewsAudio – Energy Fuels. Inc. (NYSE: UUUU) (TSX: EFR) announces the availability of a broadcast titled, “America’s National Security Blind Spot: Uranium and Rare Earth Element Production.”To hear the AudioPressRelease from NetworkNewsAudio please visit: http://nnw.fm/UhK2q or The NetworkNewsAudio News Podcast.To read the full editorial version please visit: http://nnw.fm/N14rtThe current global health crisis has revealed our nation’s soft underbelly of vulnerability to foreign sources of critical materials. America’s reliance on crucial medicines and supplies from adversarial nations like China has sounded a clarion call for U.S. policymakers to think and plan smarter. The current crisis has also revealed that the U.S. has a dangerous reliance on certain foreign sources of...

Expediting Treatment of COVID-19 Patients and Enhancing Testing Resources for Caregivers in OklahomaWorkflow from Extraction through Real-Time PCR Using Fluidigm Microfluidics Technology and ReagentsSOUTH SAN FRANCISCO, Calif., April 23, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that OU Medicine, the University of Oklahoma and the Oklahoma Medical Research Foundation (OMRF) intend to utilize Fluidigm® microfluidics technology and certain reagents to test individuals for the SARS‑CoV‑2 virus, which causes COVID-19. The spread of this disease has been declared a global pandemic by the World Health Organization.The test, developed by OMRF and OU Health Sciences Center scientists and utilizing...

NEW YORK, April 23, 2020 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today announced that two e-posters highlighting efficacy and safety results from its Phase 3 program are available for online viewing from the cancelled Annual Regional Anesthesiology and Acute Pain Medicine Meeting hosted by the American Society of Regional Anesthesia and Pain Medicine (“ASRA”). The meeting was originally scheduled to take place April 23-25, 2020 in San Francisco, CA and was cancelled due to COVID-19 concerns.The e-poster (816) titled “Intravenous Tramadol is Effective in Management of Postoperative Pain Following Abdominoplasty: A 3-arm Randomized Controlled Trial” presents data from the Phase 3 abdominoplasty study and can be...

LIMERICK, Pa., April 23, 2020 (GLOBE NEWSWIRE) — The Victory Bancorp, Inc. (OTCQX: VTYB) announced unaudited results for the quarter ended March 31, 2020. Highlights include asset growth of $29.6 million and a $2.0 million increase in stockholders’ equity at March 31, 2020, as compared to March 31, 2019. Net income decreased $325 thousand to $179 thousand for the quarter ended March 31, 2020 as compared to the quarter ended March 31, 2019, totaling approximately $0.09 per common share. Cash dividends increased from 2.5 cents per share per quarter to 5.0 cents per share per quarter in the first quarter of 2020. Book value per share increased to $10.30.Consolidated net income for the quarter ended March 31, 2020, was $179 thousand, a decrease of $325 thousand, compared to $504 thousand for the same quarter in 2019. Deposits grew to...

Added Capital Strengthens Balance Sheet, Assures Cash Through Major Phase III OPTIMA Study Data Readout EventsSale of an Additional $2.0 Million of NOL’s Expected in the 4th Quarter of 2020LAWRENCEVILLE, N.J., April 23, 2020 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced it has received $1.82 million of net cash proceeds from the sale of approximately $1.9 million of its unused New Jersey net operating losses (NOLs) and $632,220 in funding under the Paycheck Protection Program (PPP), the federal government’s main initiative to help small businesses disrupted by the COVID-19 pandemic. The NOL sales cover the tax years 2017 and 2018 and are administered through the New Jersey Economic Development Authority’s (NJEDA) Technology Business Tax Certificate Transfer (NOL)...

SOMERSET, N.J., April 23, 2020 (GLOBE NEWSWIRE) — MTBC, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP) (“MTBC” or the “Company”), a leading provider of cloud-based healthcare IT solutions and services, today announced that it has upsized and priced its previously announced underwritten public offering of non-convertible 11% Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock”), which trades on the Nasdaq Global Market with ticker “MTBCP”. The Company has agreed to sell 720,000 shares of Series A Preferred Stock, at a public offering price of $25.00 per share, for gross proceeds to the Company of $18.0 million. The Company also granted the underwriters a 30-day option to purchase up to an additional 108,000 shares at the public offering price, less underwriting discounts and commissions. The offering...

NEW YORK, April 23, 2020 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX), an oncology company developing innovative medicines and artificial intelligence to find, fight and follow cancer, today announced that it will host a conference call and webcast to review first quarter ended March 31, 2020 financial results on Thursday, May 7, 2020, at 8:30 a.m. ET.To participate, please dial (877) 250-8889 (domestic) or (720) 545-0001 (international) and reference conference ID 7359368. A live webcast will be available in the Media Center of the Progenics website, www.progenics.com, and a replay will be available there for two weeks.About PROGENICSProgenics is an oncology company focused on the development and commercialization of innovative targeted medicines and artificial intelligence to find, fight and follow cancer,...